KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to 21.63%.

  • Medpace Holdings' EBIT Margin fell 17300.0% to 21.63% in Q4 2025 from the same period last year, while for Dec 2025 it was 21.14%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 21.14% for FY2025, which is 500.0% down from last year.
  • As of Q4 2025, Medpace Holdings' EBIT Margin stood at 21.63%, which was down 17300.0% from 21.49% recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' EBIT Margin ranged from a high of 23.37% in Q4 2024 and a low of 15.25% during Q2 2021
  • For the 5-year period, Medpace Holdings' EBIT Margin averaged around 19.32%, with its median value being 19.63% (2022).
  • Per our database at Business Quant, Medpace Holdings' EBIT Margin plummeted by -34000bps in 2021 and then surged by 58500bps in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' EBIT Margin stood at 17.78% in 2021, then grew by 9bps to 19.39% in 2022, then decreased by -10bps to 17.52% in 2023, then skyrocketed by 33bps to 23.37% in 2024, then fell by -7bps to 21.63% in 2025.
  • Its EBIT Margin was 21.63% in Q4 2025, compared to 21.49% in Q3 2025 and 20.94% in Q2 2025.